THE COST-EFFECTIVENESS OF AMBISOME FOR ASYMPTOMATIC CRYPTOCOCCAL INFECTION
Screening for cryptococcal antigen (CrAg) among those with advanced HIV disease and treating asymptomatic CrAg+ with fluconazole is lifesaving. However, fluconazole monotherapy still results in 25% mortality.1 Enhanced preemptive treatment options are being evaluated to prevent cryptococcal meningitis. Single dose Ambisome (at 10mg/kg) plus fluconazole is being prospectively evaluated for preemptive treatment in asymptomatic CrAg+.…